Keaton Smetana

Dr. Keaton Smetana


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2019 in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Verified
Journal Article
Closed access
PDF file
DHDrayton A. Hammond
Drayton A. Hammond
PGPayal K. Gurnani
Payal K. Gurnani
AFAlexander H. Flannery
Alexander H. Flannery
KSKeaton Smetana
Keaton Smetana
JWJennifer C. Westrick
Jennifer C. Westrick
MRMegan A. Rech
Megan A. Rech

1 April 2021 in Endocrine Practice
Verified
Journal Article
Closed access
EFEileen R. Faulds
Eileen R. Faulds
LJLaureen Jones
Laureen Jones
MMMolly Mcnett
Molly Mcnett
KSKeaton Smetana
Keaton Smetana
CMCasey C. May
Casey C. May
KDKathleen Dungan
Kathleen Dungan

1 December 2016 in Journal of Critical Care
Verified
Journal Article
Closed access
KSKeaton Smetana
Keaton Smetana
ACAaron M. Cook
Aaron M. Cook
MBMelissa L. Thompson Bastin
Melissa L. Thompson Bastin
DODouglas R. Oyler
Douglas R. Oyler

31 December 2015 in Journal of Thrombosis and Thrombolysis
Verified
Journal Article
Closed access
PDF file
GJG. Morgan Jones
G. Morgan Jones
MEMichael J. Erdman
Michael J. Erdman
KSKeaton Smetana
Keaton Smetana
KMKerry M. Mohrien
Kerry M. Mohrien
JVJoseph E. Vandigo
Joseph E. Vandigo
LELucas Elijovich
Lucas Elijovich

25 September 2017 in Journal of Thrombosis and Thrombolysis
Verified
Journal Article
Closed access
PDF file
KSKeaton Smetana
Keaton Smetana
JDJessie Dunne
Jessie Dunne
KPKevin Parrott
Kevin Parrott
GDGeorge A. Davis
George A. Davis
ACAmy C. Schmelzer Collier
Amy C. Schmelzer Collier
SSSusan Smyth
Susan Smyth

1 January 2016 in The Journal of Pediatric Pharmacology and Therapeutics
Verified
Journal Article
Closed access
ETEmma M. Tillman
Emma M. Tillman
KSKeaton Smetana
Keaton Smetana
LBLikeselam Bantu
Likeselam Bantu
MBMerrion G. Buckley
Merrion G. Buckley
There have been a number of agents that have been tried for treatment of gastroparesis over the past 3 decades, with varying levels of success. Guidelines exist for the management of gastroparesis in adults; however, even though the cause of gastroparesis in children is similar to that in adults, no guidelines exist for treating pediatric gastroparesis as studies on the topic are limited. With what little information we have on pediatric gastroparesis, medications used in children's studies do not seem to demonstrate the same results as in adult patients with gastroparesis; thus, future studies of whether certain medications are effective for treating pediatric gastroparesis and at what dose still need to be conducted. Pharmacological treatment options for pediatric gastroparesis do not show a clear correlation of resolving or even maintaining gastroparesis-associated symptoms or disease state. This article reviews the available studies of drugs that have shown some efficacy, with an emphasis on pediatric studies.